Unclassifiable interstitial lung diseases: Clinical characteristics and survival

Respirology ◽  
2016 ◽  
Vol 22 (3) ◽  
pp. 494-500 ◽  
Author(s):  
Charlotte Hyldgaard ◽  
Elisabeth Bendstrup ◽  
Athol U. Wells ◽  
Ole Hilberg
2020 ◽  
Author(s):  
Ryosuke Kamei ◽  
HIROYUKI YAMASHITA ◽  
Yuko Takahashi ◽  
Hiroshi Kaneko

Abstract Background: Organizing pneumonia (OP) accounts for ~10% of the interstitial lung diseases in patients diagnosed with rheumatoid arthritis (RA). There are only a few published studies that have described RA-associated OP (RA–OP), each with comparatively few study participants. Furthermore, despite the high frequency of secondary flareups, no studies to date have identified factors that predict RA–OP recurrence. This study aimed to clarify the clinical characteristics of RA–OP, to determine the relationship between OP and RA exacerbations, and to identify predictors of RA–OP disease recurrence.Methods: The data of 33 patients with RA–OP admitted to our hospital between 2006 and 2016 were retrospectively analysed.Results: RA onset preceded OP in 82% of patients; OP preceded or co-occurred with RA in 9% each. The median [Q1, Q3] age at first OP onset was 64.0 [55.0, 68.0] years and 5.5 [1.0, 19.3] years after RA onset. At OP onset, 42% of events exhibited unilateral shadows and 76% had normal KL-6; RA disease control remained good in 52% and was exacerbate d in only 18%. Ten (30%) patients experienced OP recurrence with an interval of 13.0 [7.5, 22.5] months between events, with a rate of first recurrence of 127 per 1,000 person-years. Compared with 14 non-recurrent cases, 10 recurrent cases showed lower age at first OP (59.5 years vs. 67.1 years; p = 0.043) and shorter period from RA to first OP (6.4 vs. 14.2 years; p = 0.047) and included more OP-preceding patients (30% vs. 0%; p = 0.029) and more ever-smokers (80% vs. 36%; p = 0.032). OP-preceding patients showed shorter median recurrence-free survival time (15 vs. 136 months; p = 0.009) and higher recurrence risk (hazard ratio, 5.5; p = 0.021). Conclusions: RA–OP showed a high recurrence rate but no association with RA exacerbation. Four predictors of RA–OP recurrence were identified.


Medicine ◽  
2021 ◽  
Vol 100 (13) ◽  
pp. e25322
Author(s):  
Masamichi Komatsu ◽  
Hiroshi Yamamoto ◽  
Yoshiaki Kitaguchi ◽  
Satoshi Kawakami ◽  
Mina Matsushita ◽  
...  

Author(s):  
Nematillo Aralov ◽  
Nargiza Makhmatmuradova ◽  
Parvina Zakiryaeva

In order to study the frequency of occurrence, clinical characteristics, and diagnosis of interstitial pneumonia in the pulmonary department of hospitals, a retrospective analysis of case histories of 22 patients with nonspecific interstitial pneumonia who were hospitalized in the pulmonology department of the Samarkand city medical association in 2018-2019 was performed. An increase was found in patients with interstitial lung diseases, which are observed more often in women of working age, with prevalence of dyspnea, weakness, cough in the clinic, and the importance of the use of imaging technologies is indicated. Consultation of a pulmonologist is recommended for patients with rheumatic diseases.


2002 ◽  
Vol 30 (Supplement) ◽  
pp. A127
Author(s):  
Claudia I Olvera ◽  
Liliana Rojas ◽  
Joel O Ortega ◽  
Julio C Robledo

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Takuma Isshiki ◽  
Kazuya Koyama ◽  
Sakae Homma ◽  
Susumu Sakamoto ◽  
Akira Yamasaki ◽  
...  

AbstractTOLLIP polymorphism has been implicated in the development and prognosis of idiopathic pulmonary fibrosis (IPF), mainly in whites. However, ethnic differences in the characteristics of other interstitial pneumonia (non-IPF) subtypes are unclear. We evaluated the association between the rs3750920 genotype and the clinical characteristics of Japanese patients with fibrosing interstitial lung diseases (ILD). We genotyped 102 patients with fibrosing ILD (75 IPF and 27 non-IPF patients) and analyzed the interaction between the rs3750920 genotype distribution and their clinical characteristics. The overall frequencies of the C/C, C/T, and T/T genotypes were 69%, 25%, and 6%, respectively. The proportion of minor T allele carriers was larger in IPF patients than in non-IPF patients (37% vs. 15%, P = 0.031). In addition, survival at 3 years was significantly better for carriers than for non-carriers of the T allele. There was no significant association between genotype distribution and change in pulmonary function after introduction of antifibrotic agents. The frequency of the minor T allele of rs3750920 was low in Japanese patients with fibrosing ILD, particularly in non-IPF patients. Carriers of the minor T allele had better survival than non-carriers. Presence of the T allele might thus be an indicator of better outcomes for fibrosing ILD.


Author(s):  
N Buda ◽  
M Piskunowicz ◽  
M Porzezińska ◽  
W Kosiak ◽  
Z Zdrojewski

2018 ◽  
Vol 1 (1) ◽  
pp. 25-29
Author(s):  
Mirgolib RAКHIMOV ◽  
◽  
Nematilla ARALOV ◽  
Shukhrat Ziyadullaev

Sign in / Sign up

Export Citation Format

Share Document